|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-25
|
|
pubmed:abstractText |
Metabolic encephalopathy is one of the crucial manifestations of carnitine deficiency. In psychiatric patients, low serum carnitine levels may result from chronic valproate therapy. Despite the widespread use of valproate in psychiatry, neither carnitine deficiency nor supplementation has been studied in a psychiatric population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1538-1145
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5-14
|
|
pubmed:meshHeading |
pubmed-meshheading:20098226-Adult,
pubmed-meshheading:20098226-African Americans,
pubmed-meshheading:20098226-Aged,
pubmed-meshheading:20098226-Antimanic Agents,
pubmed-meshheading:20098226-Brain Diseases, Metabolic,
pubmed-meshheading:20098226-Carnitine,
pubmed-meshheading:20098226-Cognition Disorders,
pubmed-meshheading:20098226-Female,
pubmed-meshheading:20098226-Humans,
pubmed-meshheading:20098226-Male,
pubmed-meshheading:20098226-Mental Disorders,
pubmed-meshheading:20098226-Middle Aged,
pubmed-meshheading:20098226-Neuropsychological Tests,
pubmed-meshheading:20098226-Retrospective Studies,
pubmed-meshheading:20098226-Sex Factors,
pubmed-meshheading:20098226-Treatment Outcome,
pubmed-meshheading:20098226-Valproic Acid
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review.
|
|
pubmed:affiliation |
South Carolina Department of Mental Health and University of South Carolina School of Medicine, Columbia, SC, USA.mirocuturic@yahoo.com
|
|
pubmed:publicationType |
Journal Article
|
